NET LOSS PER SHARE (Details) - Schedule of dilutive shares - shares	3 Months Ended
Mar. 31, 2022	Mar. 31, 2021
Anti-dilutive shares	79,508,625	82,926,574
Convertible debt [Member]
Anti-dilutive shares	11,687,855	8,993,106
Stock options [Member]
Anti-dilutive shares	30,516,666	516,666
Warrants to purchase shares of common stock [Member]
Anti-dilutive shares	37,304,104	73,416,802

Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration